Northwire Canada EditionTuesday, July 14, 2026
Northwire
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
Earnings

WELL Health to Report Fourth Quarter and Year End 2025 Financial Results on March 19, 2026

WELL · Price

Executive Summary

  • WELL Health Technologies Corp. will publish its Fiscal Q4 and Year‑End 2025 financial results on Thursday, March 19, 2026, before market open.
  • A conference call and webcast will be held at 1:00 pm ET (10:00 am PT) the same day, hosted by CEO Hamed Shahbazi and CFO Eva Fong.

Key Details

  • Release Timing: Fiscal Q4 and Year‑End 2025 results for the period ended December 31, 2025 will be released before market open on March 19, 2026.
  • Conference Call: Scheduled for Thursday, March 19, 2026 at 1:00 pm ET (10:00 am PT).
  • Hosts: Hamed Shahbazi – Chairman & Chief Executive Officer; Eva Fong – Chief Financial Officer.
  • Dial‑in Numbers: International Toll 1‑289‑514‑5100; North American Toll‑Free 1‑800‑717‑1738.
  • Webcast Access: Register via well.company/events or the provided link in the release.

Notable Quotes

(No direct quotes were included in the release.)

Read the original news release →

More from WELL HEALTH TECHNOLOGIES CORP. J